Wintech Nano
688757
CHANGFU CO.,LTD
871396
DIER CHEMICAL
831304
4
CHENGUANG MEDICAL
430300
5
TLC
873576
US Stock MarketDetailed Quotes
GLUE Monte Rosa Therapeutics
- 5.670
- -0.160-2.74%
Trading Mar 25 11:46 ET
348.76MMarket Cap-5.79P/E (TTM)
5.870High5.480Low211.43KVolume5.830Open5.830Pre Close1.18MTurnover0.62%Turnover RatioLossP/E (Static)61.51MShares12.40052wk High1.56P/B193.11MFloat Cap3.21052wk Low--Dividend TTM34.06MShs Float45.560Historical High--Div YieldTTM6.69%Amplitude2.440Historical Low5.586Avg Price1Lot Size
Monte Rosa Therapeutics Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 75.62M | 60.65M | 9.22M | 4.7M | 1.06M | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --75.62M | --60.65M | --9.22M | --4.7M | --1.06M | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | 9.37%156.73M | 36.66%47.64M | -3.31%35.74M | 0.31%37.34M | 5.11%36.01M | 27.52%143.31M | 7.31%34.86M | 30.34%36.97M | 36.69%37.22M | 40.97%34.26M |
| Selling and administrative expenses | 9.78%35.17M | 13.57%8.78M | -6.17%8.13M | 13.96%9.28M | 19.74%8.99M | 17.26%32.04M | 1.40%7.73M | 23.38%8.66M | 29.39%8.15M | 17.49%7.5M |
| -General and administrative expense | 9.78%35.17M | 13.57%8.78M | -6.17%8.13M | 13.96%9.28M | 19.74%8.99M | 17.26%32.04M | 1.40%7.73M | 23.38%8.66M | 29.39%8.15M | 17.49%7.5M |
| Research and development costs | 9.25%121.56M | 43.23%38.87M | -2.44%27.62M | -3.51%28.06M | 1.01%27.03M | 30.81%111.27M | 9.12%27.14M | 32.63%28.31M | 38.88%29.08M | 49.34%26.76M |
| Operating profit | 43.40%-81.11M | 137.30%13M | 28.24%-26.53M | 12.30%-32.64M | -2.01%-34.95M | -27.52%-143.31M | -7.31%-34.86M | -30.34%-36.97M | -36.69%-37.22M | -40.97%-34.26M |
| Net non-operating interest income expense | 13.20%10.57M | 9.59%2.6M | 29.86%2.89M | 14.55%2.64M | 0.21%2.44M | 147.98%9.33M | 18.99%2.37M | 123.37%2.23M | 266.56%2.3M | 1,535.57%2.44M |
| Non-operating interest income | 13.20%10.57M | 9.59%2.6M | 29.86%2.89M | 14.55%2.64M | 0.21%2.44M | 147.98%9.33M | 18.99%2.37M | 123.37%2.23M | 266.56%2.3M | 1,535.57%2.44M |
| Other net income (expense) | 140.12%416K | 100.26%2K | -666.67%-153K | 23.19%-53K | 387.04%620K | -971.43%-1.04M | -175.27%-779K | -42.55%27K | -151.49%-69K | -197.74%-216K |
| Gain on sale of security | 139.21%416K | 100.26%2K | -666.67%-153K | 43.01%-53K | 387.04%620K | -10,710.00%-1.06M | -175.27%-779K | -57.14%27K | -169.40%-93K | -325.00%-216K |
| Special income (charges) | --0 | --0 | --0 | --0 | ---- | -77.98%24K | --0 | --0 | --24K | ---- |
| -Gain on sale of property,plant,equipment | --0 | --0 | --0 | --0 | ---- | -77.98%24K | --0 | --0 | --24K | ---- |
| Income before tax | 48.06%-70.13M | 146.89%15.6M | 31.47%-23.79M | 14.09%-30.06M | 0.48%-31.89M | -24.44%-135.01M | -8.10%-33.27M | -27.07%-34.71M | -32.18%-34.99M | -33.87%-32.04M |
| Income tax | 660.36%2.57M | 9,936.36%2.16M | -58.24%71K | 32.63%252K | 83K | 338K | -22K | 170K | 190K | 0 |
| Net income | 46.29%-72.7M | 140.41%13.44M | 31.60%-23.86M | 13.84%-30.31M | 0.22%-31.97M | -24.75%-135.35M | -8.02%-33.25M | -27.69%-34.88M | -32.90%-35.18M | -33.87%-32.04M |
| Net income continuous Operations | 46.29%-72.7M | 140.41%13.44M | 31.60%-23.86M | 13.84%-30.31M | 0.22%-31.97M | -24.75%-135.35M | -8.02%-33.25M | -27.69%-34.88M | -32.90%-35.18M | -33.87%-32.04M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 46.29%-72.7M | 140.41%13.44M | 31.60%-23.86M | 13.84%-30.31M | 0.22%-31.97M | -24.75%-135.35M | -8.02%-33.25M | -27.70%-34.88M | -32.90%-35.18M | -33.87%-32.04M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 46.29%-72.7M | 140.41%13.44M | 31.60%-23.86M | 13.84%-30.31M | 0.22%-31.97M | -24.75%-135.35M | -8.02%-33.25M | -27.70%-34.88M | -32.90%-35.18M | -33.87%-32.04M |
| Basic earnings per share | 62.74%-0.98 | 137.67%0.2185 | 58.57%-0.29 | 39.44%-0.43 | 18.46%-0.53 | -14.35%-2.63 | 7.94%-0.58 | -20.69%-0.7 | -24.56%-0.71 | -27.45%-0.65 |
| Diluted earnings per share | 62.74%-0.98 | 137.67%0.2185 | 58.57%-0.29 | 39.44%-0.43 | 18.46%-0.53 | -14.35%-2.63 | 7.94%-0.58 | -20.69%-0.7 | -24.56%-0.71 | -27.45%-0.65 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Market Insights
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025